KOLON TISSUEGENE HIGHLIGHTS LONG-TERM SAFETY DATA AND POTENTIAL U.S. FDA PATHWAY FOR TG-C AT OARSI WORLD CONGRESS

Kolon TissueGene, Inc. South Korea Maryland

THE WORLD'S MOST PRESTIGIOUS OSTEOARTHRITIS SOCIETY (OARSI) HELD FOR THE FIRST TIME IN KOREA  LONG-TERM SAFETY DATA FROM OVER 15 YEARS SUPPORT THE SAFETY PROFILE OF TG-C, WITH PRELIMINARY SIGNS OF POTENTIAL EFFICACY BENEFITSView original content:https://www.prnewswire.co.uk/news-releases/kolon-tissuegene-highlights-long-term-safety-data-and-potential-us-fda-pathway-for-tg-c-at-oarsi-world-congress-302439726.html